TY - JOUR
T1 - The human genome project
T2 - Benefits and risks to society
AU - Wattanapitayakul, Suvara
AU - Schommer, Jon C.
PY - 1999
Y1 - 1999
N2 - The human genome project was initiated in 1990 to study the structure and characteristics of human DNA that are important for understanding gene functions and their relation to diseases. The large-scale genome research has driven the technology advancement in genetic testing, drug design, gene therapy, and other genetic related areas such as pharmacogenetics. Although the project reveals potential benefits, it raises ethical, legal, and social issues. The outcomes of individuals' genetic information disclosure may lead to confidentiality and genetic discrimination issues. In addition, clinical relevance of genetic testing and psychological effect from the results are debatable. This article discusses the potential benefits and risks from the human genome project.
AB - The human genome project was initiated in 1990 to study the structure and characteristics of human DNA that are important for understanding gene functions and their relation to diseases. The large-scale genome research has driven the technology advancement in genetic testing, drug design, gene therapy, and other genetic related areas such as pharmacogenetics. Although the project reveals potential benefits, it raises ethical, legal, and social issues. The outcomes of individuals' genetic information disclosure may lead to confidentiality and genetic discrimination issues. In addition, clinical relevance of genetic testing and psychological effect from the results are debatable. This article discusses the potential benefits and risks from the human genome project.
KW - Human genome project
KW - Public policy
UR - http://www.scopus.com/inward/record.url?scp=84996236643&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84996236643&partnerID=8YFLogxK
U2 - 10.1177/009286159903300310
DO - 10.1177/009286159903300310
M3 - Article
AN - SCOPUS:0032772858
SN - 2168-4790
VL - 33
SP - 729
EP - 735
JO - Therapeutic Innovation and Regulatory Science
JF - Therapeutic Innovation and Regulatory Science
IS - 3
ER -
